Postoperative seizure and developmental outcomes of children with hemimegalencephaly and drug-resistant epilepsy

Seizure. 2021 Nov:92:29-35. doi: 10.1016/j.seizure.2021.08.006. Epub 2021 Aug 14.

Abstract

Objective: To evaluate seizure and developmental outcomes in the short and long term in children with hemimegalencephaly (HMEG) after surgery.

Methods: This is a cohort study of 36 children who underwent surgery for HMEG were followed up for at least 1 year postoperatively. The Griffiths Mental Development Scales, Ages and Stages Questionnaire version 3, and Peabody Developmental Motor Scales were used to assess development.

Results: The median postoperative follow-up duration was 2.7 (1.0-5.0) years, and median age at surgery was 1.9 years (5.8 months-5.9 years). At the last follow-up, 83% of children were seizure-free. the predicted probability of being seizure-free three years after surgery was 79%. The proportion of patients who were moderate to severe delay declined from 97% preoperatively to 76% at least 1 year after surgery. Catch-up, stabilization, and regression of developmental quotient (DQ) was observed in 41%, 35%, and 24% of children 3 months after surgery, respectively. The corresponding proportions during long-term follow-up were 40%, 33%, and 27%, respectively. Change of DQ shortly after surgery was negatively correlated with age at seizure onset and age at surgery. The long-term DQ was positively correlated with the preoperative DQ. Long-term change of DQ was positively correlated with change of DQ shortly after surgery.

Conclusions: Most of patients with HMEG could achieve seizure free after surgery. After surgery, the proportion of catch-up, stabilization, and regression in both short- and long-term DQ was approximately 40%, 35%, and 25%, respectively. The change of DQ shortly after surgery may be a predictor for long-term developmental change.

Keywords: Children; Development; Drug-resistant epilepsy; Hemimegalencephaly; Surgery.

MeSH terms

  • Child
  • Cohort Studies
  • Drug Resistant Epilepsy* / surgery
  • Follow-Up Studies
  • Hemimegalencephaly*
  • Humans
  • Pharmaceutical Preparations*
  • Retrospective Studies
  • Seizures
  • Treatment Outcome

Substances

  • Pharmaceutical Preparations